165 related articles for article (PubMed ID: 28155878)
1. Immune Signature of Enhanced Functional Avidity CD8
Hu Z; Zhu L; Wang J; Wan Y; Yuan S; Chen J; Ding X; Qiu C; Zhang X; Qiu C; Xu J
Sci Rep; 2017 Feb; 7():41558. PubMed ID: 28155878
[TBL] [Abstract][Full Text] [Related]
2. Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.
Hu Z; Wang J; Wan Y; Zhu L; Ren X; Qiu S; Ren Y; Yuan S; Ding X; Chen J; Qiu C; Sun J; Zhang X; Xiang J; Qiu C; Xu J
J Virol; 2014 May; 88(10):5356-68. PubMed ID: 24554667
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
Villacres MC; Zuo J; Bergmann CC
Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
[TBL] [Abstract][Full Text] [Related]
4. Immune Protection by a Cytomegalovirus Vaccine Vector Expressing a Single Low-Avidity Epitope.
Borkner L; Sitnik KM; Dekhtiarenko I; Pulm AK; Tao R; Drexler I; Cicin-Sain L
J Immunol; 2017 Sep; 199(5):1737-1747. PubMed ID: 28768725
[TBL] [Abstract][Full Text] [Related]
5. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
6. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.
Oseroff C; Peters B; Pasquetto V; Moutaftsi M; Sidney J; Panchanathan V; Tscharke DC; Maillere B; Grey H; Sette A
J Immunol; 2008 Jun; 180(11):7193-202. PubMed ID: 18490718
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.
Ren H; Ferguson BJ; Maluquer de Motes C; Sumner RP; Harman LE; Smith GL
Immunology; 2015 May; 145(1):34-49. PubMed ID: 25382035
[TBL] [Abstract][Full Text] [Related]
10. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.
Goonetilleke N; Moore S; Dally L; Winstone N; Cebere I; Mahmoud A; Pinheiro S; Gillespie G; Brown D; Loach V; Roberts J; Guimaraes-Walker A; Hayes P; Loughran K; Smith C; De Bont J; Verlinde C; Vooijs D; Schmidt C; Boaz M; Gilmour J; Fast P; Dorrell L; Hanke T; McMichael AJ
J Virol; 2006 May; 80(10):4717-28. PubMed ID: 16641265
[TBL] [Abstract][Full Text] [Related]
11. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.
Hassett DE; Slifka MK; Zhang J; Whitton JL
J Virol; 2000 Sep; 74(18):8286-91. PubMed ID: 10954526
[TBL] [Abstract][Full Text] [Related]
12. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
13. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
Jayakumar A; Castilho TM; Park E; Goldsmith-Pestana K; Blackwell JM; McMahon-Pratt D
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1204. PubMed ID: 21695103
[TBL] [Abstract][Full Text] [Related]
14. Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.
Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
J Immunol; 2004 Nov; 173(10):6284-93. PubMed ID: 15528367
[TBL] [Abstract][Full Text] [Related]
15. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
Perdiguero B; Gómez CE; Nájera JL; Sorzano CO; Delaloye J; González-Sanz R; Jiménez V; Roger T; Calandra T; Pantaleo G; Esteban M
PLoS One; 2012; 7(10):e48524. PubMed ID: 23119046
[TBL] [Abstract][Full Text] [Related]
18. High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
Carretero-Iglesia L; Couturaud B; Baumgaertner P; Schmidt J; Maby-El Hajjami H; Speiser DE; Hebeisen M; Rufer N
Front Immunol; 2019; 10():3016. PubMed ID: 31969886
[TBL] [Abstract][Full Text] [Related]
19. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
20. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
